Pulmonx is an innovative medical technology company engaged in the design, development and manufacture of therapeutic devices for the treatment of patients with severe emphysema.
Our corporate strategy is to establish a primary franchise in the emerging field of interventional pulmonology. Our product portfolio is intended to provide physicians with "intelligent" tools to expand and improve treatment options for patients.
